Astellas to develop rice-based oral cholera vaccine
Japan's Astellas has agreed to carry out clinical trials of a vaccine for serious diarrhoeal diseases which does not need to be refrigerated or injected and is produced in transgenic rice plants.
Archives for July 5, 2016
Shelf life issue halts trial of Scancell's cancer vaccine SCIB1
UK biopharma company Scancell was forced to halt trials of its flagship cancer immunotherapy SCIB1 because its supplies of the drug no longer meet quality specifications.
Corium Alzheimer's disease patch could be available by 2019
A transdermal patch formulation of the most commonly used Alzheimer's disease (AD) drug could be on the market in 2019 - two to three years earlier than expected.